Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2000, p. 2638-2644, Vol. 44, No. 10
Department of Pharmaceutical Screening,
Nippon Roche Research Center, 200 Kajiwara, Kamakura, Kanagawa
Prefecture 247,1 New Ceramics
Department, Asahi Optical Co., Ltd., Itabashi-ku, Tokyo
174-8639,2 Medical Institute of
Bioregulation, Department of Molecular and Cellular Biology, Kyushu
University, 3-1-1 Maidaishi, Higashi-ku Fukuoka, Fukuoka
812-8582,4 and Screening Technology,
Bayer Yakuhin Research Center Kyoto, 6-5-1-3 Kunimidai, Soraku-gun,
Kyoto,5 Japan, and Pharma Division,
Preclinical Research, F. Hoffmann-La Roche Ltd., CH-4070
Basel,3 and Drug Discovery Research,
WHO/TDR, World Health Organization, CH-1211 Geneva
27,6 Switzerland
Received 24 January 2000/Returned for modification 13 April
2000/Accepted 28 June 2000
Hematin polymerization is a parasite-specific process that enables
the detoxification of heme following its release in the lysosomal
digestive vacuole during hemoglobin degradation, and represents both an
essential and a unique pharmacological drug target. We have developed a
high-throughput in vitro microassay of hematin polymerization based on
the detection of 14C-labeled hematin incorporated into
polymeric hemozoin (malaria pigment). The assay uses 96-well filtration
microplates and requires 12 h and a Wallac 1450 MicroBeta liquid
scintillation counter. The robustness of the assay allowed the rapid
screening and evaluation of more than 100,000 compounds. Random
screening was complemented by the development of a pharmacophore
hypothesis using the "Catalyst" program and a large amount of data
available on the inhibitory activity of a large library of
4-aminoquinolines. Using these methods, we identified "hit"
compounds belonging to several chemical structural classes that had
potential antimalarial activity. Follow-up evaluation of the
antimalarial activity of these compounds in culture and in the
Plasmodium berghei murine model further identified compounds with actual antimalarial activity. Of particular interest was
a triarylcarbinol (Ro 06-9075) and a related benzophenone (Ro 22-8014)
that showed oral activity in the murine model. These compounds are
chemically accessible and could form the basis of a new antimalarial
medicinal chemistry program.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Hematin Polymerization Assay as a High-Throughput
Screen for Identification of New Antimalarial Pharmacophores
*
Corresponding author. Mailing address: F. Hoffmann-La
Roche Ltd, PRPI-D, Building 70/138, CH-4070 Basel, Switzerland. Phone: (61) 688 84 11. Fax: (61) 688 27 29. E-mail:
arnulf.dorn{at}roche.com.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»